STAP1 and acute lymphoblastic leukemia: Limma analyses revealed STAP1 to be the probeset with the highest fold-change in BCR-ABL1-like and non-BCR-ABL1-like B-other patients compared to remaining BCP-ALL cases (fold change = 2.88, adjusted p-value < 0.0001; Supplementary Table S1).